ReviewBiomedicines2026

Evaluating the Therapeutic Impact of Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer.

Keren Rouvinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.